NEPHERYS

Serial Number 79281417
Registration 6127127
700

Registration Progress

Application Filed
Feb 5, 2020
Under Examination
Approved for Publication
May 13, 2020
Published for Opposition
Jun 2, 2020
Registered
Aug 18, 2020

Attorney Assistance

Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20200818)
Due: Aug 18, 2026 243 days

Trademark Image

NEPHERYS

Basic Information

Serial Number
79281417
Registration Number
6127127
Filing Date
February 5, 2020
Registration Date
August 18, 2020
Published for Opposition
June 2, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 18, 2020
Registration
Registered
Classes
005

Rights Holder

BIOCODEX

99
Address
7 avenue Gallieni
F-94250 GENTILLY
FR

Ownership History

BIOCODEX

Original Applicant
99
FR

BIOCODEX

Owner at Publication
99
FR

BIOCODEX

Original Registrant
99
FR

USPTO Deadlines

Next Deadline
243 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20200818)
Due Date
August 18, 2026
Grace Period Ends
February 18, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

13 events
Date Code Type Description Documents
Nov 14, 2025 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Nov 1, 2020 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Oct 9, 2020 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Oct 8, 2020 FIMP P FINAL DISPOSITION PROCESSED Loading...
Sep 17, 2020 GPAR P GRANT OF PROTECTION CREATED, TO BE SENT TO IB Loading...
Aug 18, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 2, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 13, 2020 NPUB O NOTICE OF PUBLICATION Loading...
Apr 27, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 23, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 27, 2020 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Mar 23, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 19, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical products for hyperoxaluria treatment

Classification

International Classes
005